Wellfully Ltd
ASX:WFL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inspirisys Solutions Ltd
NSE:INSPIRISYS
|
IN |
Wellfully Ltd
Capital Expenditures
Wellfully Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Wellfully Ltd
ASX:WFL
|
Capital Expenditures
-AU$146.8k
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Capital Expenditures
-AU$9k
|
CAGR 3-Years
37%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Capital Expenditures
-AU$29m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Capital Expenditures
-AU$37k
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-29%
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Capital Expenditures
-AU$182.7k
|
CAGR 3-Years
5%
|
CAGR 5-Years
-66%
|
CAGR 10-Years
N/A
|
|
|
Nyrada Inc
ASX:NYR
|
Capital Expenditures
-AU$2.2k
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Wellfully Ltd
Glance View
Wellfully Ltd. is a science-based wellness company, which engages in the research and development of dermaportation and enhance transdermal polymer technologies. The company is headquartered in Leederville, Western Australia. The company went IPO on 2000-05-29. The firm is focused on research and development for its Dermaportation and Enhanced Transdermal Polymer (ETP) drug delivery technologies. The company is also focused on developing magnetic micro-array and powerless drug delivery technologies and works with partners in the design and development of drug patches, applicators, brushes and devices for the pharmaceutical, healthcare, cosmetic and homecare product sectors. The firm primarily provides these partnering and collaboration services to companies in the United Kingdom, Europe, the United States and South-East Asia. The firm's subsidiaries include International Scientific Pty Ltd, Bodyguard Lifesciences Pty Ltd, Wellfully SA, Wellfully Ltd and Peros Dongguan Technology & Trading Co. Ltd.
See Also
What is Wellfully Ltd's Capital Expenditures?
Capital Expenditures
-146.8k
AUD
Based on the financial report for Dec 31, 2023, Wellfully Ltd's Capital Expenditures amounts to -146.8k AUD.
What is Wellfully Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-49%
The average annual Capital Expenditures growth rates for Wellfully Ltd have been -54% over the past three years , -49% over the past five years .
